Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,648,379

« Back to Dashboard
Patent 5,648,379 protects RELENZA and is included in one NDA.

Summary for Patent: 5,648,379

Title: Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
Abstract:Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.
Inventor(s): Von Itzstein; Laurence Mark (North Fitzroy, AU), Wu; Wen-Yang (Mount Waverley, AU), Van Phan; Tho (Carnegie, AU), Danylec; Basil (Box Hill, AU), Jin; Betty (Mount Waverly, AU), Colman; Peter Malcolm (East Melbourne, AU), Varghese; Joseph Noozhumurry (Brunswick, AU)
Assignee: Biota Scientific Management Pty., Ltd. (Melbourne, AU)
Application Number:08/325,074
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation; Use;
Patent PDF download available with subscription

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
POWDER;INHALATION021036-001Jul 26, 1999RXYes5,648,379<disabled>PROPHYLAXIS OF INFLUENZA
POWDER;INHALATION021036-001Jul 26, 1999RXYes5,648,379<disabled>TREATMENT OF INFLUENZA
POWDER;INHALATION021036-001Jul 26, 1999RXYes5,648,379<disabled>ZANAMIVIR FOR INHALATION
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,648,379

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPJ 9800Apr 24, 1990
AustraliaPK 2896Oct 19, 1990
AustraliaPK 4537Feb 11, 1991

International Patent Family for Patent: 5,648,379

Country Document Number Publication Date
South Africa9103086Dec 30, 1992
Yugoslavia74591Jun 24, 1994
Yugoslavia48741Sep 27, 1999
World Intellectual Property Organization (WIPO)9116320Oct 31, 1991
United States of America5360817Nov 01, 1994
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn